Inclusion Criteria:

• All adult and pediatric patients with a type of nervous system tumor included in a list of histopathologies will be eligible to enroll in the Neuro-Oncology Program Registry and Biobank.  This list may be modified in the future.  The current list includes:
  • Astrocytoma;
  • Dysembryoplastic Neuroepithelial Tumor;
  • Ependymoma;
  • Ganglioglioma;
  • Glioma;
  • Gliosarcoma;
  • Medulloblastoma;
  • Meningioma;
  • Mixed Oligodendroglioma-Astrocytoma;
  • Oligodendroglioma;
  • Pilocytic Astrocytoma;
  • Pleomorphic Xanthoastrocytoma;
  • Schwannoma;
  • Subependymal Giant Cell Astrocytoma;
  • Subependymoma;
  • Primitive neuro-ectodermal tumors;
  • Vitreoretinal Lymphoma (adult subjects only);
  • Primary CNS lymphoma;
  • Brain metastases including, but not limited to, melanoma, breast, lung and renal cancers;
  • Pineal region tumors;
  • Germ cell tumors;
  • Hemangiopericytoma;
  • Diffuse Intrinsic Pontine Glioma (DIPG);
  • Intracranial solitary fibrous tumors;
  • Neurofibroma.
• Pregnant women will be included in this registry.

Exclusion Criteria:

• Patients with a histopathology other than that listed above.
• Patients whose pathologic diagnosis cannot be confirmed will not be eligible to enroll in the Neuro-Oncology Program Registry and Biobank.